- Sunesis Launches Phase 3 VALOR Trial of Vosaroxin in AML - December 21, 2010
- Epocrates Announces Acquisition of Modality - November 16, 2010
- NexusDx Merges With ITC To Create Global POC Diagnostics Provider - November 4, 2010
- Cadence Pharmaceuticals Receives FDA Approval of OFIRMEV (tm) - November 2, 2010
- Ion Torrent Selected as World Economic Forum Technology Pioneer - September 1, 2010
- Ion Torrent To Be Acquired by Life Technologies - August 17, 2010
- EnteroMedics Achieves Major Milestones for the Maestro System - August 2, 2010
- Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary - July 30, 2010
- BrainCells Announces Results From Exploratory Phase 2A Trial of BCI-540 - June 14, 2010
- IDev Technologies Announces European Launch of SUPERA VERITAS (TM) System - May 17, 2010
- BrainCells Gets First U.S. Patent For Drug Combinations To Modulate Neurogenesis - April 29, 2010
- MAP Pharmaceuticals Announces FREEDOM-301 P3 LEVADEX (TM) Trial Results - April 14, 2010
- Metabolex Initiates Research Collaboration with Takeda - April 13, 2010
- EnteroMedics Extends Neuroblocking Technology R&D Collaboration- March 17, 2010
- Sunesis to Proceed with P3 Trial of Voreloxin in Acute Myeloid Leukemia - February 25, 2010
- BioSeek Acquisition by Asterand Completed - February 18, 2010
- Sunesis Grants Carmot Therapeutics License to its Drug Discovery Technology - February 8, 2010
- Merus Closes EUR 21.7M Series B Financing - January 29, 2010
- Sunesis Announces Publication of Voreloxin Data in Leukemias - January 14, 2010
